Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh. Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune blood test is the first such test offered for children with liver or intestine transplantation.
View Top Employees from PlexisionWebsite | http://www.plexision.com |
Revenue | $1 million |
Employees | 7 (6 on RocketReach) |
Founded | 2008 |
Address | 4424 Penn Ave Suite 202, Pittsburgh, Pennsylvania 15221, US |
Phone | (412) 224-2776 |
Technologies |
HTML,
Google Analytics,
reCAPTCHA
+10 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services |
Competitors | Astute Medical, Augurex Life Sciences Corp., Biosignatures Ltd, Ent Associates Of San Diego, Gero |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular Plexision employee's phone or email?
The Plexision annual revenue was $1 million in 2024.
Pradeep Sethi is the Medical Director of Plexision.
6 people are employed at Plexision.
Plexision is based in Pittsburgh, Pennsylvania.
The NAICS codes for Plexision are [54, 54171, 541, 541714, 5417].
The SIC codes for Plexision are [87, 873].